Lakeside Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Lakeside Advisors's GILD Position: Q2 2026 in Review
Lakeside Advisors increased its Gilead Sciences (GILD) stake by 0.01% in Q2 2026, buying an estimated $132 and bringing the position to 8,840 shares worth $1.12M. The position accounts for 0.7% of the portfolio, ranked #28.
Lakeside Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.23M in Q1 2026. 1,245 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Lakeside Advisors held 8,840 shares of Gilead Sciences worth $1.12M as of Q2 2026.
- Lakeside Advisors bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
- Gilead Sciences made up 0.7% of Lakeside Advisors's portfolio in Q2 2026, its #28 holding.
- Lakeside Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
- Lakeside Advisors's Gilead Sciences position peaked at $1.23M in Q1 2026.
- 1,245 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.